-

INVESTOR ALERT: Securities Class Action Filed Against Beyond Meat – Contact Kirby McInerney LLP

NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed on behalf of investors who acquired Beyond Meat, Inc. (“Beyond Meat” or the “Company”) (NASDAQ:BYND) securities during the period of February 27, 2025 through November 11, 2025, inclusive (“the Class Period”).

If you suffered a loss on your Beyond Meat investments, you have until March 24, 2026 to request lead plaintiff appointment. Courts do not consider lead plaintiff applications submitted after this deadline. If you choose to take no action, you may remain an absent class member. For more information about the lawsuit:

[CONTACT THE FIRM IF YOU SUFFERED A LOSS]

What Is This Lawsuit About? The lawsuit alleges that (i) the book value of long-lived assets exceeded their fair value, making it highly likely that the Company would be required to record a material, non-cash impairment charge; (ii) the foregoing was likely to impair Beyond Meat’s ability to timely file its periodic filings with the U.S. Securities and Exchange Commission.

On October 24, 2025, Beyond Meat reported preliminary financial results for the third quarter of 2025 (“Q3 2025”). Therein, the Company announced that it “expects to record a non-cash impairment charge for the three months ended September 27, 2025, related to certain of its long-lived assets,” which it “expected to be material.” On this news, Beyond Meat shares declined by $0.65 per share, or approximately 22.89%, to close at $2.19 on October 24, 2025.

Then, on November 3, 2025, the Company delayed its earnings announcement for 3Q 25, citing the need for more time to complete its impairment review. On this news, Beyond Meat shares declined by $0.27 per share, or approximately 16.27%, to close at $1.39 on November 3, 2025.

On November 10, 2025, Beyond Meat announced financial results for 3Q 2025, reporting a loss from operations for the quarter of $112.3 million, which included a $77.4 million non-cash impairment charge “related to certain of the Company’s long-lived assets.” On this news, Beyond Meat shares declined by $0.12 per share, or approximately 8.96%, to close at $1.22 on November 11, 2025.

Finally, on November 11, 2025, Beyond Meat disclosed on its 3Q 2025 earnings call with investors and analysts that “[t]he total impairment amount of $77.4 million was . . . allocated to PP&E, operating lease ROU assets and prepaid lease costs on our balance sheet.” On this news, Beyond Meat’s shares fell an additional $0.11 per share, or approximately 8.61%, to close at $1.12 per share on November 12, 2025.

[LEARN MORE ABOUT THE LAWSUIT]

The Lead Plaintiff Appointment Process. The federal securities laws permit any investor who acquired eligible securities during the class period to seek appointment as lead plaintiff in a class action lawsuit. Courts typically appoint the investor(s) with the largest financial loss in the case and the ability to represent the class rather than investors with simply the largest investment portfolio. Courts regularly appoint individual investors, whether acting alone or as a group, as lead plaintiffs. The rights of any investor who bought shares during the class period are generally already protected. However, lead plaintiffs have the power to influence case strategy and have a say in settlement decisions, as well as decisions concerning allocation of settlement funds among class members.

[LEARN MORE ABOUT THE LEAD PLAINTIFF PROCESS]

What Should I Do? If you purchased or otherwise acquired Beyond Meat securities, have information, or would like to learn more about this investigation, please contact Lauren Molinaro of Kirby McInerney LLP by email at investigations@kmllp.com, or fill out the contact form below, to discuss your rights or interests with respect to these matters at no cost.

Kirby McInerney LLP is a New York-based plaintiffs’ law firm concentrating in securities, antitrust, whistleblower, and consumer litigation. The firm’s efforts on behalf of shareholders in securities litigation have resulted in recoveries totaling billions of dollars. Additional information about the firm can be found at Kirby McInerney LLP’s website.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contacts

Kirby McInerney LLP
Lauren Molinaro, Esq.
212-699-1171
https://www.kmllp.com
https://securitiesleadplaintiff.com/
investigations@kmllp.com

Kirby McInerney LLP

NASDAQ:BYND

Release Versions

Contacts

Kirby McInerney LLP
Lauren Molinaro, Esq.
212-699-1171
https://www.kmllp.com
https://securitiesleadplaintiff.com/
investigations@kmllp.com

More News From Kirby McInerney LLP

CARVANA CO. INVESTOR ALERT: Kirby McInerney LLP Announces Investigation Into Potential Securities Fraud

NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP is investigating potential claims against Carvana Co. (“Carvana” or the “Company”) (NYSE:CVNA). The investigation concerns whether the Company and/or members of its senior management may have violated federal securities laws or engaged in other unlawful business practices. [LEARN MORE ABOUT THE INVESTIGATION] What Happened? On January 28, 2025, Gotham City Research short seller report alleged that the Company’s reported profitabilit...

CPNG DEADLINE NOTICE: Coupang, Inc. Investors Encouraged to Contact Kirby McInerney LLP By February 17, 2026

NEW YORK--(BUSINESS WIRE)--If you suffered a loss on your investment in Coupang, Inc. (“Coupang” or the “Company”) (NYSE:CPNG), contact Lauren Molinaro by email at investigations@kmllp.com, or fill out the contact form below to discuss your rights or interests in the securities fraud class action lawsuit at no cost. Investors have until February 17, 2026 to ask the Court to appoint them as lead plaintiff. Courts do not consider applications filed after this deadline. The lead plaintiff oversees...

REMINDER: agilon health, inc. Investors With Significant Losses Must Act By March 2, 2026

NEW YORK--(BUSINESS WIRE)--Kirby McInerney LLP reminds agilon health, inc. (“agilon” or the “Company”) (NYSE:AGL) investors of the March 2, 2026 deadline to seek the role of lead plaintiff in a pending federal securities class action. Courts do not consider applications filed after this deadline. The lead plaintiff oversees the litigation on behalf of the class and may influence key decisions, including litigation strategy and settlement. Courts regularly appoint individual investors as lead pl...
Back to Newsroom